Impact of maternal COVID 19 vaccination during pregnancy evaluated in large study
Maternal mRNA COVID-19 vaccination during pregnancy is associated with lower risks of severe neonatal morbidity, neonatal death, and neonatal intensive care unit admission, as revealed by a large population-based cohort study in Ontario, Canada. The study focused on assessing severe neonatal morbidity (SNM), neonatal death, neonatal intensive care unit (NICU) admission, neonatal readmission, and hospital admission up to 6 months of age among infants born to vaccinated and unvaccinated mothers.
The study, involved singleton live births expected between May 1, 2021, and September 2, 2022. A total of 142,006 infants were included, with 85,670 exposed to one or more COVID-19 vaccine doses in utero.
The findings revealed that infants born to vaccinated mothers experienced lower risks of SNM, neonatal death, and NICU admission. Specifically, the adjusted risk ratios (aRR) indicated significant risk reduction for these outcomes.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.